Marinus Pharmaceuticals (NASDAQ:MRNS) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Marinus Pharmaceuticals their estimated earnings by 27.4%, reporting an EPS of $-0.53 versus an estimate of $-0.73, which surprised analysts.
Revenue was up $9,943,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.04, which was followed by a 3.96% drop in the share price the next day.
Here’s a look at Marinus Pharmaceuticals’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.69 | -0.45 | -0.51 | -0.60 |
| EPS Actual | -0.65 | -0.74 | -0.55 | -0.51 |
| Revenue Estimate | 2.70M | 2.57M | 1.04M | 420.00K |
| Revenue Actual | 1.91M | 1.81M | 1.55M | 171.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
